PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2098151
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2098151
Antimicrobial Susceptibility Testing Market Insights, Competitive Landscape, and Market Forecast - 2033
The global Antimicrobial Susceptibility Testing (AST) Market is witnessing strong growth due to the increasing prevalence of antimicrobial resistance (AMR), rising demand for rapid diagnostic solutions, growing infectious disease burden, and advancements in microbiology testing technologies. Antimicrobial susceptibility testing plays a crucial role in identifying the effectiveness of antibiotics and other antimicrobial agents against pathogens, enabling healthcare providers to select appropriate treatments and improve patient outcomes.
According to recent market analysis, the Antimicrobial Susceptibility Testing Market is valued at USD 6.6 Billion in 2026 and is projected to reach USD 10.46 Billion by 2033, expanding at a CAGR of 7% during the forecast period. The market expansion is driven by increasing hospital-acquired infections, growing awareness regarding antimicrobial resistance, and the adoption of advanced automated diagnostic platforms across healthcare facilities.
Market Insights
Antimicrobial susceptibility testing refers to laboratory techniques used to determine whether microorganisms such as bacteria and fungi are susceptible or resistant to specific antimicrobial drugs. These tests support clinical decision-making by helping physicians select effective therapies while reducing unnecessary antibiotic use.
The rising global threat of antimicrobial resistance has accelerated the adoption of AST solutions. Healthcare organizations and regulatory bodies are increasingly emphasizing antimicrobial stewardship programs to promote responsible antibiotic usage and reduce the spread of drug-resistant infections.
Technological advancements are transforming the AST landscape, with automated testing systems, molecular diagnostics, artificial intelligence-based analysis, and rapid identification technologies improving testing speed and accuracy. These innovations allow laboratories to deliver faster results compared with conventional methods, supporting timely treatment decisions.
The increasing number of infectious disease cases, expanding diagnostic laboratory networks, and growing investments in healthcare infrastructure are further contributing to market growth.
Market Drivers
One of the key factors driving the Antimicrobial Susceptibility Testing Market is the growing prevalence of antimicrobial-resistant infections. The increasing misuse and overuse of antibiotics have accelerated the development of resistant pathogens, creating a strong need for accurate susceptibility testing solutions.
The rising incidence of hospital-acquired infections is another major growth driver. Hospitals and healthcare facilities are adopting AST technologies to monitor infection patterns, optimize antibiotic therapies, and improve infection control practices.
Increasing demand for rapid diagnostic methods is also supporting market expansion. Traditional susceptibility testing methods often require extended processing times, whereas automated and rapid AST platforms provide faster results, enabling quicker clinical interventions.
Additionally, government initiatives and global antimicrobial resistance surveillance programs are encouraging healthcare providers to invest in advanced diagnostic technologies. Funding for infectious disease research and improved laboratory infrastructure is expected to create favorable market conditions.
Business Opportunities
The Antimicrobial Susceptibility Testing Market offers significant growth opportunities through the development of rapid, accurate, and cost-effective diagnostic solutions. Companies are increasingly focusing on molecular testing platforms, automation technologies, and artificial intelligence-driven diagnostic tools to improve testing efficiency.
Emerging economies present attractive opportunities due to expanding healthcare infrastructure, increasing infectious disease awareness, and rising investments in diagnostic laboratories. Countries across Asia Pacific, Latin America, and the Middle East & Africa are strengthening microbiology testing capabilities, creating new market opportunities.
The integration of advanced technologies such as machine learning, digital microbiology, and automated interpretation systems is expected to unlock further growth potential. These technologies can improve laboratory workflow, reduce turnaround time, and support personalized antimicrobial treatment strategies.
Partnerships between diagnostic companies, healthcare providers, and research institutions are also expected to accelerate innovation and increase adoption of AST solutions globally.
Regional Analysis
North America holds a leading position in the global Antimicrobial Susceptibility Testing Market due to advanced healthcare infrastructure, strong presence of diagnostic companies, and high adoption of automated laboratory systems. The region benefits from increased focus on antimicrobial stewardship programs and infectious disease monitoring initiatives.
Europe represents a significant market supported by strong healthcare systems, government-led antimicrobial resistance control programs, and increasing investments in microbiology diagnostics. Countries across the region are adopting advanced AST technologies to improve infection management and reduce antibiotic resistance.
The Asia Pacific region is expected to experience substantial growth during the forecast period. Rising healthcare expenditure, increasing prevalence of infectious diseases, improving laboratory infrastructure, and growing awareness regarding antimicrobial resistance are driving demand for AST solutions across countries such as China, India, and Japan.
Latin America is witnessing steady market growth due to expanding healthcare access, increasing diagnostic testing capabilities, and rising efforts to improve infectious disease management.
The Middle East & Africa region is also expected to grow gradually as healthcare systems modernize and governments invest in advanced diagnostic infrastructure.
Competitive Landscape
The Antimicrobial Susceptibility Testing Market is highly competitive, with major players focusing on product innovation, strategic collaborations, acquisitions, and expansion of diagnostic portfolios. Companies are investing in automated testing systems, rapid diagnostic technologies, and integrated laboratory solutions to strengthen their market position.
Market participants are also focusing on developing solutions that provide faster results, improved accuracy, and enhanced workflow efficiency for clinical laboratories and healthcare providers.
Key Players
- Thermo Fisher Scientific Inc.
- bioMerieux S.A.
- Becton, Dickinson and Company (BD)
- Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
- Siemens Healthineers AG
- Beckman Coulter (Danaher Corporation)
- bioLoomics, Inc.
- Liofilchem Srl
- Bruker Corporation
- Oxoid (part of Thermo Fisher Scientific)
- Thermo Scientific - TREK Diagnostic Systems
- Trek Diagnostic Systems (Thermo Fisher brand)
- Hardy Diagnostics
- ELITechGroup
- Mast Group Ltd.
Future Outlook
The future of the Antimicrobial Susceptibility Testing Market remains promising as healthcare systems worldwide continue to address the growing challenge of antimicrobial resistance. Increasing demand for precision medicine, rapid diagnostics, and effective infection management solutions will continue to support market expansion.
The adoption of automated platforms, artificial intelligence-based diagnostics, and molecular testing technologies is expected to transform AST workflows by improving accuracy and reducing testing time. Additionally, rising investments in infectious disease research and healthcare modernization will create new opportunities for market participants.
As antimicrobial resistance continues to emerge as a global healthcare challenge, the demand for advanced susceptibility testing solutions is expected to grow steadily, positioning the market for sustained development through 2033.
Market Segmentation
By Test Type:
- Antibacterial Testing
- Antifungal Testing
- Others
By Method:
- E-TEST
- Disk Diffusion
- Rapid Automation Method
- Others
By Application:
- Diagnostics
- Drug Discovery & Development
- Others
By End Users:
- Hospitals & Clinics
- Clinical Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Antimicrobial Susceptibility Testing Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Fiver Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Antimicrobial Susceptibility Testing Market Outlook, 2020-2033
- 3.1. Global Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 3.1.1. Antibacterial Testing
- 3.1.2. Antifungal Testing
- 3.1.3. Others
- 3.2. Global Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 3.2.1. E-TEST
- 3.2.2. Disks Diffusion
- 3.2.3. Rapid Automation Method
- 3.2.4. Others
- 3.3. Global Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.3.1. Diagnostics
- 3.3.2. Drug Discovery & Development
- 3.3.3. Others
- 3.4. Global Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 3.4.1. Hospitals & Clinics
- 3.4.2. Clinical Laboratories
- 3.4.3. Pharmaceutical & Biotechnology Companies
- 3.4.4. Others
- 3.5. Global Antimicrobial Susceptibility Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Antimicrobial Susceptibility Testing Market Outlook, 2020-2033
- 4.1. North America Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 4.1.1. Antibacterial Testing
- 4.1.2. Antifungal Testing
- 4.1.3. Others
- 4.2. North America Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 4.2.1. E-TEST
- 4.2.2. Disks Diffusion
- 4.2.3. Rapid Automation Method
- 4.2.4. Others
- 4.3. North America Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.3.1. Diagnostics
- 4.3.2. Drug Discovery & Development
- 4.3.3. Others
- 4.4. North America Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 4.4.1. Hospitals & Clinics
- 4.4.2. Clinical Laboratories
- 4.4.3. Pharmaceutical & Biotechnology Companies
- 4.4.4. Others
- 4.5. North America Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 4.5.2. U.S. Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 4.5.3. U.S. Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 4.5.4. U.S. Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 4.5.5. Canada Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 4.5.6. Canada Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 4.5.7. Canada Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 4.5.8. Canada Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Antimicrobial Susceptibility Testing Market Outlook, 2020-2033
- 5.1. Europe Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 5.1.1. Antibacterial Testing
- 5.1.2. Antifungal Testing
- 5.1.3. Others
- 5.2. Europe Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 5.2.1. E-TEST
- 5.2.2. Disks Diffusion
- 5.2.3. Rapid Automation Method
- 5.2.4. Others
- 5.3. Europe Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.3.1. Diagnostics
- 5.3.2. Drug Discovery & Development
- 5.3.3. Others
- 5.4. Europe Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 5.4.1. Hospitals & Clinics
- 5.4.2. Clinical Laboratories
- 5.4.3. Pharmaceutical & Biotechnology Companies
- 5.4.4. Others
- 5.5. Europe Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.2. Germany Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.3. Germany Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.4. Germany Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.5. Italy Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.6. Italy Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.7. Italy Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.8. Italy Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.9. France Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.10. France Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.11. France Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.12. France Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.13. U.K. Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.14. U.K. Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.15. U.K. Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.16. U.K. Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.17. Spain Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.18. Spain Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.19. Spain Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.20. Spain Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.21. Russia Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.22. Russia Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.23. Russia Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.24. Russia Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.25. Rest of Europe Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.26. Rest of Europe Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.27. Rest of Europe Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.28. Rest of Europe Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, 2020-2033
- 6.1. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 6.1.1. Antibacterial Testing
- 6.1.2. Antifungal Testing
- 6.1.3. Others
- 6.2. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 6.2.1. E-TEST
- 6.2.2. Disks Diffusion
- 6.2.3. Rapid Automation Method
- 6.2.4. Others
- 6.3. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.3.1. Diagnostics
- 6.3.2. Drug Discovery & Development
- 6.3.3. Others
- 6.4. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 6.4.1. Hospitals & Clinics
- 6.4.2. Clinical Laboratories
- 6.4.3. Pharmaceutical & Biotechnology Companies
- 6.4.4. Others
- 6.5. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.2. China Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.3. China Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.4. China Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.5. Japan Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.6. Japan Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.7. Japan Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.8. Japan Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.9. South Korea Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.10. South Korea Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.11. South Korea Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.12. South Korea Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.13. India Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.14. India Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.15. India Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.16. India Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.17. Southeast Asia Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.18. Southeast Asia Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.19. Southeast Asia Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.20. Southeast Asia Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.21. Rest of SAO Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.22. Rest of SAO Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.23. Rest of SAO Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.24. Rest of SAO Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Antimicrobial Susceptibility Testing Market Outlook, 2020-2033
- 7.1. Latin America Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 7.1.1. Antibacterial Testing
- 7.1.2. Antifungal Testing
- 7.1.3. Others
- 7.2. Latin America Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 7.2.1. E-TEST
- 7.2.2. Disks Diffusion
- 7.2.3. Rapid Automation Method
- 7.2.4. Others
- 7.3. Latin America Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.3.1. Diagnostics
- 7.3.2. Drug Discovery & Development
- 7.3.3. Others
- 7.4. Latin America Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 7.4.1. Hospitals & Clinics
- 7.4.2. Clinical Laboratories
- 7.4.3. Pharmaceutical & Biotechnology Companies
- 7.4.4. Others
- 7.5. Latin America Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 7.5.2. Brazil Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 7.5.3. Brazil Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 7.5.4. Brazil Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 7.5.5. Mexico Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 7.5.6. Mexico Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 7.5.7. Mexico Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 7.5.8. Mexico Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 7.5.9. Argentina Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 7.5.10. Argentina Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 7.5.11. Argentina Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 7.5.12. Argentina Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 7.5.13. Rest of LATAM Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 7.5.14. Rest of LATAM Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 7.5.15. Rest of LATAM Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 7.5.16. Rest of LATAM Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, 2020-2033
- 8.1. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 8.1.1. Antibacterial Testing
- 8.1.2. Antifungal Testing
- 8.1.3. Others
- 8.2. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 8.2.1. E-TEST
- 8.2.2. Disks Diffusion
- 8.2.3. Rapid Automation Method
- 8.2.4. Others
- 8.3. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.3.1. Diagnostics
- 8.3.2. Drug Discovery & Development
- 8.3.3. Others
- 8.4. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 8.4.1. Hospitals & Clinics
- 8.4.2. Clinical Laboratories
- 8.4.3. Pharmaceutical & Biotechnology Companies
- 8.4.4. Others
- 8.5. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.2. GCC Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.3. GCC Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.4. GCC Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 8.5.5. South Africa Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.6. South Africa Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.7. South Africa Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.8. South Africa Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 8.5.9. Egypt Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.10. Egypt Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.11. Egypt Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.12. Egypt Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 8.5.13. Nigeria Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.14. Nigeria Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.15. Nigeria Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.16. Nigeria Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 8.5.17. Rest of Middle East Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.18. Rest of Middle East Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.19. Rest of Middle East Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.20. Rest of Middle East Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Thermo Fisher Scientific Inc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. bioMerieux U.S.A.
- 9.4.3. Becton, Dickinson and Company (BD)
- 9.4.4. Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
- 9.4.5. Siemens Healthineers AG
- 9.4.6. Beckman Coulter (Danaher Corporation)
- 9.4.7. bioLoomics, Inc.
- 9.4.8. Liofilchem Srl
- 9.4.9. Bruker Corporation
- 9.4.10. Oxoid (part of Thermo Fisher Scientific)
- 9.4.1. Thermo Fisher Scientific Inc.
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
